Pirfenidone improves survival in IPF: results from a real-life study-Reference-Cited by-同舟云学术

Pirfenidone improves survival in IPF: results from a real-life study

Published:2018-11-23 Issue:1 Volume:18 Page:
ISSN:1471-2466
Container-title:BMC Pulmonary Medicine
language:en
Short-container-title:BMC Pulm Med

Author:

Margaritopoulos George A.,Trachalaki Athina^ORCID,Wells Athol U.,Vasarmidi Eirini,Bibaki Eleni,Papastratigakis George,Detorakis Stathis,Tzanakis Nikos,Antoniou Katerina M.

Publisher

Springer Science and Business Media LLC

Subject

Pulmonary and Respiratory Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12890-018-0736-z.pdf

Reference25 articles.

1. Margaritopoulos GA, Romagnoli M, Poletti V, Siafakas NM, Wells AU, Antoniou KM. Recent advances in the pathogenesis and clinical evaluation of pulmonary fibrosis. Eur Respir Rev. 2012;21:48-56.

2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66(1):7–30.

3. Hutchinson J, Fogarty A, Hubbard R, McKeever T. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review. Eur Respir J. 2015;46(3):795–806.

4. Margaritopoulos GA, Vasarmidi E, Antoniou KM. Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy. Core Evidence. 2016;11:11–22.

5. Raghu G, Rochwerg B, Zhang Y, Garcia CA, Azuma A, Behr J, Brozek JL, Collard HR, Cunningham W, Homma S, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med. 2015;192(2):e3–19.

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disorders of fatty acid metabolism and imbalance in the ratio of monounsaturated fatty acids promote the development of pulmonary fibrosis;International Immunopharmacology;2024-09

2. Intra-articular sustained-release of pirfenidone as a disease-modifying treatment for early osteoarthritis;Bioactive Materials;2024-09

3. Safety, effectiveness, and usefulness of higher-dose tablets of generic pirfenidone in patients with IPF: a nationwide observational study in South Korea;Frontiers in Pharmacology;2024-08-09

4. Use of pirfenidone in fibrotic interstitial lung diseases and beyond: a review;Frontiers in Medicine;2024-08-06

5. Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias;Respiratory Research;2024-07-31